BioMarin Pharmaceutical
BMRN
#1434
Rank
NZ$20.72 B
Marketcap
$108.75
Share price
-3.00%
Change (1 day)
-23.05%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2023 (TTM): $1.27

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is $1.33. In 2022 the company made an earnings per share (EPS) of $1.31 an increase over its 2021 EPS that were of -$0.60.

EPS history for BioMarin Pharmaceutical from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.27-3.06%
2022$1.31-319.62%
2021-$0.60-107.38%
2020$8.10-3485.71%
2019-$0.24-67.44%
2018-$0.73-34.85%
2017-$1.13-83.21%
2016-$6.72263.89%
2015-$1.8518.68%
2014-$1.56-28.91%
2013-$2.1934.74%
2012-$1.6293.88%
2011-$0.84-124.5%
2010$3.42
2009N/A-100%
2008$0.55-300%
2007-$0.27-54.29%
2006-$0.60-67.89%
2005-$1.86-62.54%
2004-$4.97136.59%
2003-$2.10-15.17%
2002-$2.48-11.59%
2001-$2.8056.19%
2000-$1.7910.53%
1999-$1.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$17.50-1,415.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.46-284.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.82-462.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.43 308.43%๐Ÿ‡ซ๐Ÿ‡ท France
-$1.09-182.19%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.88 41.27%๐Ÿ‡บ๐Ÿ‡ธ USA